טוען...

Alogliptin, a Dipeptidyl Peptidase‐4 Inhibitor, Alleviates Atrial Remodeling and Improves Mitochondrial Function and Biogenesis in Diabetic Rabbits

BACKGROUND: There is increasing evidence implicating atrial mitochondrial dysfunction in the pathogenesis of atrial fibrillation. In this study, we explored whether alogliptin, a dipeptidyl peptidase‐4 inhibitor, can prevent mitochondrial dysfunction and atrial remodeling in a diabetic rabbit model....

תיאור מלא

שמור ב:

מידע ביבליוגרפי
הוצא לאור ב:	J Am Heart Assoc
Main Authors:	Zhang, Xiaowei, Zhang, Zhiwei, Zhao, Yungang, Jiang, Ning, Qiu, Jiuchun, Yang, Yajuan, Li, Jian, Liang, Xue, Wang, Xinghua, Tse, Gary, Li, Guangping, Liu, Tong
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	John Wiley and Sons Inc. 2017
נושאים:	Original Research
גישה מקוונת:	https://ncbi.nlm.nih.gov/pmc/articles/PMC5524117/ https://ncbi.nlm.nih.gov/pubmed/28507060 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.117.005945
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

Alogliptin, a Dipeptidyl Peptidase‐4 Inhibitor, Alleviates Atrial Remodeling and Improves Mitochondrial Function and Biogenesis in Diabetic Rabbits

פריטים דומים